4//SEC Filing
Shaaltiel Yoseph 4
Accession 0001209191-10-018791
CIK 0001006281other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 9:11 PM ET
Size
8.0 KB
Accession
0001209191-10-018791
Insider Transaction Report
Form 4
Shaaltiel Yoseph
DirectorExecutive VP, R&D
Transactions
- Sale
Common Stock
2010-03-24$7.08/sh−202,700$1,435,116→ 933,754 total - Sale
Common Stock
2010-03-23$7.02/sh−127,300$893,646→ 1,136,454 total - Sale
Common Stock
2010-03-25$7.00/sh−50,000$350,000→ 883,754 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001385118
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 9:11 PM ET
- Size
- 8.0 KB